MiGenTra Egypt is using well established CHO cell lines which has been shown to be a popular, robust cell line for the production of recombinant proteins. These proteins are synthesized by large-scale cultivation of genetically engineered cells, which contain artificially transfected genes encoding for the proteins for specific requirements.
Recombinant protein therapy continues to provide innovative and effective therapies for several diseases and has brought significant improvement in the healthcare services.